Ken Olivier

Kenneth J Olivier Jr, Ph.D. is an accomplished professional in the field of toxicology and drug development, currently serving as the Executive Vice President of Development at Neutrolis Inc since December 2023. With extensive experience as a Drug Development Consultant at Olivier KOnsulting since September 2015, Olivier has held various leadership roles including Vice President of Nonclinical Development at TScan Therapeutics and Executive Director at Morphic Therapeutic. Prior to these positions, Olivier gained significant expertise at companies such as Torque Therapeutics, Acceleron Pharma, and Merrimack Pharmaceuticals, where responsibilities included overseeing toxicology studies and managing cross-functional teams. Educational credentials include a Ph.D. in Veterinary Biomedical and Clinical Sciences from Oklahoma State University and a Bachelor of Science in Toxicology from the University of Louisiana Monroe.